The founders of iGenTraX are scientists with international reputation in the fields of physical and analytical chemistry. Thorsten Benter and Oliver J. Schmitz hold tenured professorship at the Universities of Wuppertal and Duisburg-Essen (Germany), respectively. Klaus Brockmann was a senior physical chemist at the University of Wuppertal with outstanding knowledge in technical support and with great experience in API, particularly APLI.
iGenTraX is a strongly research oriented small business.
This classification appears to be implausible. Looking at the current API MS development activities, a couple of major large enterprises are basically dominating the market spending huge amounts of R&D money.
How can a small business successfully compete in this environment?